Genetics Cardiovascular Diseases
Heart failure symptoms may be caused by inherited genetic abnormalities that alter the structure of the heart muscle. The electrical system of the heart can be impacted by gene abnormalities as well, which may result in irregular cardiac rhythms.
-  Hypertrophic Cardiomyopathy (HCM) idiopathic
-  Arrhythmogenic right ventricular cardiomyopathy (ARVC)
Related Conference of Genetics Cardiovascular Diseases
March 09-10, 2026
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
Singapore City, Singapore
June 18-19, 2026
16th International Conference on Human Genetics and Genetic Diseases
Singapore City, Singapore
June 18-19, 2026
19th International Conference on Genomics & Pharmacogenomics
Singapore City, Singapore
Genetics Cardiovascular Diseases Conference Speakers
Recommended Sessions
- Biochemical Genetics
- Cancer Genetics
- Classical Genetics
- Clinical Genetics
- Common Genetic Diseases
- Comparative Genomics
- Gene Function Prediction& Genome Annotation
- Gene Therapy
- Genetic Counseling
- Genetic Epidemiology
- Genetic Medicine
- Genetics Cardiovascular Diseases
- Genome Integrity
- Immunogenetics
- Lethal Genetic Diseases
- Neurogenetics
- Nutrigenetics & Nutrigenomics
- Pharmacogenomics
- Phylogenetics
- Population Genetics
- Yoga practice and genetic changes
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)